

The Prion Lab of the Proteomics Research Unit belonging the Centre for Cooperative Research in Biosciences - CIC bioGUNE, has been recently inaugurated and is located in Building No. 502 in the Bizkaia Technology Park. The laboratory is committed to a thorough study of transmissible spongiform encephalopaties (TSEs), like the so-called mad-cow disease, among others.
March 10, 2010
The Basque company IDOKI SCF Technologies, located in the Bizkaia Technology Park, has released a new range of products for pharmaceutical use derived from its research studies on supercritical fluid technology. IDOKI’s processes mainly focus on the identification of active principles in natural raw materials. Once these target compounds are selected, IDOKI outlines the technological process to extract them from top quality raw materials, purify them and incorporate them in standard or new formulations.
March 8, 2010
Donostia Hospital co-authors a paper on dementia in Nature Genetics
Researchers from the Donostia Hospital from San Sebastián have been involved in the international study that has identified a genetic factor in frontotemporal dementia unknown until now. This neurodegenerative disease comprises 20% of all types of dementia and affects 1-2% of the population over 65 years. The study, which could help to delay or minimise the disease, has involved more than 100 centres from 20 countries and has been published in the Nature Genetics scientific journal.
March 5, 2010
CIC biomaGUNE’s researchers launch breast cancer diagnostic method
Researchers from the Centre for Cooperative Research in Biomaterials (CIC biomaGUNE) have developed the STREM (Stress Relaxation Microscopy) experimental methodology for complete mechanical characterisation of different biomaterials. The new method, whose description and preliminary application were published in the Journal of Biomechanics, may become a powerful detection and diagnostics tool for many diseases such as breast cancer.
March 3, 2010
March 2, 2010 > The Basque Government and MCC to cooperate in health sector
March 1, 2010 > UPV/EHU’s research in the top 20 of the Journal of the American Chemical Society
February 26, 2010 > Faes Farma and Pharmakine involved in Oncologica to fight cancer
February 25, 2010 > CIC bioGUNE’s researchers hit on a mechanism explaining cancer-related DNA mutations
February 23, 2010 > Progenika set to grow in the US with million-dollar investment by COFIDES
February 22, 2010 > Likuid Nanotek places 2M€ in new production plant
February 22, 2010 > UPV/EHU’s research in Microbiology front cover
February 18, 2010 > Dynakin to operate in over 40 countries after signing with German company Dr. Regenold
February 15, 2010 > Biobide’s major scientific advances at the 7th Annual Screening Europe
February 12, 2010 > Mertxe de Renobales of the UPV/EHU awarded prize for work on genetically modified crops by the International Society of Bioethics
February 11, 2010 > Genetadi Biotech inaugurates new premises and expands its diagnostics and genetic analysis business
February 10, 2010 > CIC bioGUNE´s Structural Biology Unit, on ETB.
February 9, 2010 > Renal Foundation acquires shares in OWL Genomics through MD Renal stock swap
February 4, 2010 > BTI authored the third worldwide clinical trial on the use of antibiotics in oral implantology
February 1, 2010 > CIC bioGUNE’s first lustrum closes with 120 scientific papers, 9 registered patents and 4 new companies
February 1, 2010 > CIC biomaGUNE´s new Molecular Imaging Unit, on ETB
January 29, 2010 > Progenika opens new development centre in Bizkaia with €8M investment
January 25, 2010 > Biolan reaches an agreement to market biosensors for viticultural use in Argentina
January 21, 2010 > Researchers from the UPV/EHU and Ciber-BBN receive national recognition from the Spanish Association for Pharmaceutical Law
January 18, 2010 > Proteomika and Donostia Hospital launch chip to detect pneumonia and other infections
January 15, 2010 > Research at the Santiago Hospital in Vitoria reveals brain damage from cannabis is reversible
January 13, 2010 Faes Farma wins exclusive agreement with Merck Sharp & Dohme to market anti-inflammatory drug in Spain
January 11, 2010 > CIC biomaGUNE, CIC nanoGUNE and DIPC take part in a European project developing a novel nanobiosensor to diagnose diseases
January 3, 2010 > CEIT, Tecnun and Berkeley promote an MSc in Biomedical Engineering